Integra director granted 24,338 common shares

HILL BARBARA B reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HILL BARBARA B reported acquisition or exercise transactions in this Form 4 filing.

INTEGRA LIFESCIENCES HOLDINGS CORP reported that director Barbara B. Hill received two stock awards of the company’s Common Stock on May 7, 2026. She was granted 17,700 shares and 6,638 shares at a price of $0.00 per share as equity compensation. Following these awards, she directly owns 151,191 shares, and an additional 36,350 shares are held indirectly by a trust.

Insider Trade Summary

Grant/Award: 24,338 shares

Grant/Award 3 txns

Insider HILL BARBARA B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,638	$0.00	$0.00
Grant/Award	Common Stock	17,700	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 151,191 shares (Direct); Common Stock — 36,350 shares (Indirect, By Trust)

Key Figures

Stock award 1: 17,700 shares Stock award 2: 6,638 shares Total shares awarded: 24,338 shares +3 more

6 metrics

Stock award 1 17,700 shares Common Stock grant to Barbara B. Hill on May 7, 2026

Stock award 2 6,638 shares Additional Common Stock grant on May 7, 2026

Total shares awarded 24,338 shares Sum of two Common Stock grants on May 7, 2026

Direct holdings after awards 151,191 shares Common Stock directly owned by Barbara B. Hill after transactions

Indirect trust holdings 36,350 shares Common Stock held indirectly “By Trust”

Acquisition transactions count 2 transactions Grant, award, or other acquisition type entries

Key Terms

Common Stock, Grant, award, or other acquisition, By Trust, indirect ownership

4 terms

Common Stock financial

"The transactions involved the issuer’s Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"Transaction code A is described as “Grant, award, or other acquisition”."

By Trust financial

"An indirect ownership entry lists nature of ownership as “By Trust”."

indirect ownership financial

"The filing reports 36,350 shares as indirect ownership by a trust."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did INTEGRA LIFESCIENCES (IART) report for Barbara B. Hill?

Barbara B. Hill received two stock awards of Common Stock. She was granted 17,700 shares and 6,638 shares on May 7, 2026 at no cost, reflecting equity compensation rather than open-market buying.

How many Integra Lifesciences (IART) shares did Barbara B. Hill hold after the Form 4 awards?

After the reported awards, Barbara B. Hill directly held 151,191 shares of Integra Lifesciences Common Stock. A separate indirect position of 36,350 shares is held by a trust, giving a combined reported interest across direct and indirect holdings.

Were the Integra Lifesciences (IART) Form 4 transactions open-market purchases or sales?

The Form 4 transactions were classified as grants or awards, not market trades. Both entries used transaction code A, described as “Grant, award, or other acquisition,” with a per-share price of $0.00, indicating compensation-related awards.

What does ‘By Trust’ mean for Barbara B. Hill’s Integra Lifesciences (IART) holdings?

“By Trust” indicates 36,350 Integra Lifesciences shares are held indirectly through a trust. This is reported as indirect ownership on the Form 4, separate from Barbara B. Hill’s directly held 151,191 shares of Common Stock after the reported awards.

How many acquisition-type transactions were reported in this Integra Lifesciences (IART) Form 4?

The filing shows two acquisition-type transactions. Both involve Common Stock with transaction code A, which the Form 4 describes as a “Grant, award, or other acquisition,” consistent with stock-based compensation granted to director Barbara B. Hill.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HILL BARBARA B

(Last) (First) (Middle)

1100 CAMPUS ROAD

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		A		6,638	A	$0	133,491	D
Common Stock	05/07/2026		A		17,700	A	$0	151,191	D
Common Stock								36,350	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Michael D. Hutchinson; Attorney-in-Fact for Barbara Hill	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)